Literature DB >> 15355459

Changes in endothelium-dependent arterial dilation before and after subtotal thyroidectomy in subjects with hyperthyroidism.

Xiang Guang-da1, Cao Hong-yan, Zeng Xian-mei.   

Abstract

OBJECTIVE: This case-control study was carried out to assess the alteration of endothelium-dependent arterial dilation before and after subtotal thyroidectomy in subjects with hyperthyroidism. PATIENTS AND METHODS: The study subjects included 12 patients with hyperthyroidism and 39 apparently healthy individuals. We performed a subtotal thyroidectomy on the hyperthyroid patients. The endothelium-dependent arterial dilation was determined with a high-resolution ultrasound method in each patient at the hyperthyroid stage before treatment (stage H), the euthyroid stage induced immediately before surgery (stage E), and the transient hypothyroid stage 1 or 2 months after surgery (stage L).
RESULTS: The flow-mediated arterial dilation decreased significantly from H to E and from E to L (P < 0.001). As compared with H, baseline blood flow decreased markedly at stages E and L (P < 0.001). The flow-mediated arterial dilation and baseline blood flow in the control subjects were very close to those at stage E of the hyperthyroid patients. The absolute change in the flow-mediated arterial dilation showed significant negative correlation with the changes in TSH (r =-0.86, P < 0.001), lipoprotein (a) [Lp(a)] (r =-0.77, P < 0.001) and low density lipoprotein (LDL) (r =-0.79, P < 0.001), and significant positive correlation with changes in fT3 (r =+0.88, P < 0.001). The absolute change in the baseline blood flow showed significant positive correlation with the change in fT3 (r =+0.85, P < 0.001) and significant negative correlation with the change in TSH (r =-0.63, P < 0.01).
CONCLUSION: The endothelium-dependent arterial dilation increases significantly in untreated hyperthyroid patients, and decreases markedly after a subtotal thyroidectomy. Therefore, we conclude that the endothelium is more responsive to reactive hyperaemia in the hyperthyroid than the euthyroid state.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15355459     DOI: 10.1111/j.1365-2265.2004.02112.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  4 in total

1.  Endothelial function is not changed during short-term withdrawal of thyroxine in patients with differentiated thyroid cancer and low cardiovascular risk.

Authors:  Hyuk-Jae Chang; Kyung Won Kim; Sung Hee Choi; Soo Lim; Kyoung Un Park; Do Joon Park; Dong Joo Choi; Hak C Jang; Bo Youn Cho; Young Joo Park
Journal:  Yonsei Med J       Date:  2010-07       Impact factor: 2.759

2.  Lipid abnormalities and cardiometabolic risk in patients with overt and subclinical thyroid disease.

Authors:  Melpomeni Peppa; Grigoria Betsi; George Dimitriadis
Journal:  J Lipids       Date:  2011-07-18

3.  Evaluation of endothelial function in exogenous subclinical hyperthyroidism and the effect of treatment.

Authors:  Sayed Mohammad Hosseini; Elham Khosravi Bakhtyari; Kiyan Heshmat-Ghahdarijani; Noushin Khalili
Journal:  Adv Biomed Res       Date:  2016-11-28

4.  Thyroid hormones regulate both cardiovascular and renal mechanisms underlying hypertension.

Authors:  Stanislovas S Jankauskas; Marco B Morelli; Jessica Gambardella; Angela Lombardi; Gaetano Santulli
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-12-29       Impact factor: 3.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.